Author Question: A client receiving emetogenic chemotherapy should receive which of the following medications as a ... (Read 68 times)

segrsyd

  • Hero Member
  • *****
  • Posts: 530
A client receiving emetogenic chemotherapy should receive which of the following medications as a premedication?
 
  a. promethazine c. ondansetron
  b. droperidol d. meclizine

Question 2

The nurse is aware of a special warning on the label of droperidol about the risk of:
 
  a. hypersensitivity reaction. c. vertigo.
  b. sudden cardiac death. d. increased intracranial pressure.



lkoler

  • Sr. Member
  • ****
  • Posts: 358
Answer to Question 1

ANS: C

Feedback
A Incorrect: This is not used as a premedication to prevent nausea.
B Incorrect: This is not used as a premedication to prevent nausea.
C Correct: This is the most common serotonin-blocking agent used as a premed for chemotherapy.
D Incorrect: This is most often used to prevent and treat motion sickness.

Answer to Question 2

ANS: B

Feedback
A Incorrect: There is not a special warning for hypersensitivity reaction for this drug.
B Correct: There is a special warning for sudden cardiac death related to this drug.
C Incorrect: There is not a special warning for vertigo related to this drug.
D Incorrect: There is not a special warning for increased intracranial pressure.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

About 600,000 particles of skin are shed every hour by each human. If you live to age 70 years, you have shed 105 pounds of dead skin.

Did you know?

Blood in the urine can be a sign of a kidney stone, glomerulonephritis, or other kidney problems.

Did you know?

The calories found in one piece of cherry cheesecake could light a 60-watt light bulb for 1.5 hours.

Did you know?

Many medications that are used to treat infertility are injected subcutaneously. This is easy to do using the anterior abdomen as the site of injection but avoiding the area directly around the belly button.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library